跳至主要内容
临床试验/NCT05851755
NCT05851755Enrolling By Invitation不适用

Italian Lung Cancer Observational Study

The Mediterranean Institute for Transplantation and Advanced Specialized Therapies1 个研究点 分布在 1 个国家目标入组 1,000 人开始时间: 2023年4月1日最近更新:
适应症

试验速览

阶段
不适用
状态
Enrolling By Invitation
发起方
入组人数
1,000
试验地点
1
主要终点
Lung cancer surgery outcomes

研究概览

简要总结

LUCENT is an observational study focused on malignant pulmonary and tracheo-bronchial disease. It involves a large proportion of reference Italian thoracic surgery centers. The relevance of the study is related to the epidemiology of lung cancer in the world - also known as "Big Killer" - and the high mortality rates both in males and females.

The aim of his prospective study is to collect a large bulk of postoperative patients' outcome data and to produce up-to-date descriptive statistics of patients undergoing surgery for lung cancer. These results will be pivotal to compare the clinical results of all the relevant specialities involved in the care of lung cancer such as medical oncologists and radiation oncologists.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients with lung cancer
  • informed consent

排除标准

  • alcohol or drug abuse
  • age < 18
  • inability to express consent

结局指标

主要结局

Lung cancer surgery outcomes

时间窗: 5 years

Benchmarking national outcome data of the treatment of lung cancer

次要结局

未报告次要终点

研究者

发起方
The Mediterranean Institute for Transplantation and Advanced Specialized Therapies
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Italian Lung Cancer Observational Study | 临床试验